2 results match your criteria: "Jiangdu People's Hospital Affiliated to Yangzhou University Medical School[Affiliation]"
Neoadjuvant Chemoradiotherapy Does Not Contribute to Worse Survival in Pathological Node-Negative Rectal Cancer.
Front Oncol
March 2021
Department of General Surgery, Jiangdu People' s Hospital Affiliated to Yangzhou University Medical School, Yangzhou, China.
The prognostic significance of ypN0 rectal cancer with comparison to pN0 disease still remains poorly defined. This study aimed to compare the prognosis of ypN0 and pN0 rectal cancer. Eligible patients were identified from the SEER18 registries research database (the latest data up to date was on April 15, 2019).
View Article and Find Full Text PDFRe-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer.
Front Oncol
November 2020
Department of General Surgery, Jiangdu People's Hospital Affiliated to Yangzhou University Medical School, Yangzhou, China.
Objective: We conducted this large population-based study to re-evaluate the survival paradox between stage IIB/C and stage IIIA colon cancer based on the newest staging criteria.
Methods: Colon cancer patients were recruited from the Surveillance, Epidemiology, and End Results (SEER) database using SEER*Stat software (version 8.3.